Noida, UP -- (SBWire) -- 09/11/2014 --Health conscious individuals are increasingly looking for predictive diagnostic tests for cancer. In response to the burgeoning demand, players in the industry are readily launching predictive tests. For instance, in a recent development Enzo Biochem’s Clinical Labs launched a new diagnostic test, EarlyCDT-Lung Test. Besides Enzo, other players such as CML Healthcare are also coming with new products.
Due to the evident benefits associated with earlier detection, predictive tests are gaining popularity. This interest in predictive diagnostics will continue to fuel the growth of the IVD market, which will grow with a CAGR of around 7% during 2013-2018. In our study, “In-Vitro Diagnostics Market Outlook 2018”, each region’s current and future outlook to 2018 has been discussed. Further, each market has been broken down into eight distinct clinical segmentations and their current and future outlook to 2018 has been analyzed to provide a thorough opportunity assessment.
Besides, the report has delved into the business dynamics of the major players of the market. To provide a thorough understanding of the company’s business model, company’s current and historical financials have been analyzed. Moreover, each company’s strengths and weaknesses along with their recent industrial activities have also been assessed. This will help the reader to gain a deeper insight into the current competitive landscape and position its company accordingly.
The report provides a thorough research and rational analysis of the current status and expected position of the global IVD market. The analysis of the emerging sectors and key players in the market provides a holistic view to the reader. Explaining some of the constraints faced by the industry, the study also covers the emerging trends which would have a positive impact on the market growth. Overall, the report contains key actionable insights that will help the reader to gain a deeper knowledge of the industry, identify opportunities and design suitable business strategies.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM679.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
ABOUT RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.
Demand for Predictive Cancer Diagnostics Shoots Up
‘Rising in the popularity of predictive cancer tests to fuel the growth of the IVD market’, says RNCOS.